Management and Outcome of Paediatric Septic Shock Requiring Vasoactive Therapy: A Multicentre Prospective Observational Study
Management und Outcome von pädiatrischem septischem Schock mit Bedarf an vasoaktiver Therapie: multizentrische prospektive Beobachtungsstudie
Acta Paediatrica · 11.11.2026
DOI: 10.1111/apa.70830 ↗Auf einen Blick
Bei 225 Kindern mit PSSRVT waren mehrere vasoaktive Medikamente häufig nötig. Die Gesamtmortalität lag bei 59 %; Epinephrin war das häufigste Erstlinienmedikament.
Fragestellung
Beschreibung von klinischen Merkmalen, Einsatz vasoaktiver Medikamente, Zusatztherapien und Outcomes bei PSSRVT.
Methode
Multizentrische prospektive Beobachtungsstudie in 16 PICUs zwischen 1. Oktober 2024 und 30. April 2025.
Ergebnisse
225 Patient:innen mit PSSRVT. 93 % erhielten Kochsalzlösung; 23 % ein, 45 % zwei vasoaktive Medikamente. Epinephrin 70 %, Norepinephrin 27 %. Steroide bei 53 % der vasopressor-resistenten Fälle; Mortalität 59 %.
Schlussfolgerung der Autor:innen
Bei den meisten Patient:innen waren mehrere vasoaktive Medikamente erforderlich; die Anwendungsmuster unterschieden sich von früheren Berichten. Weitere Studien sind nötig, um Auswahl und Sequenzierung zu optimieren.
Kernaussagen
- 225 Kinder mit PSSRVT in 16 PICUs
- Epinephrin am häufigsten als Erstlinienmedikament
- Gesamtmortalität 59 %
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, online erschienen am 11.11.2026. Verfasst von Muhammed Üdürgücü und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Critical Care, Ondokuz Mayıs University School of Medicine, Samsun, Turkey. Die Arbeit nennt 20 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
Aim
Although vasoactive drugs are recommended for paediatric septic shock requiring vasoactive therapy (PSSRVT), evidence on optimal agent selection remains limited. This study aimed to describe clinical characteristics, vasoactive drug use, adjunctive treatments, and outcomes of patients with PSSRVT.
Methods
This multicentre, prospective study was conducted between 1 October 2024 and 30 April 2025, across 16 Paediatric Intensive Care Units (PICUs).
Results
The study included 225 PSSRVT patients treated with vasoactive agents, with a PICU frequency of 5%. Normal saline was administered in 93% of cases (mean 29.6 ± 14.0 mL/kg). A single vasoactive drug was used in 23% of patients, while 45% received two. Epinephrine was the most common first‐line drug (70%), followed by norepinephrine (27%). Corticosteroids were used in 53% of vasopressor‐resistant cases, with a median vasoactive inotrope score (VIS) of 60 (40–100). Among patients requiring intubation due to escalating sepsis severity, the median (IQR) VIS at the time of intubation was 50 (30–70). Overall mortality was 59%.
Conclusion
Multiple vasoactive drugs were required in most patients, with usage patterns differing from previous reports. The median VIS at corticosteroid initiation was close to the VIS threshold associated with increased mortality. Further studies are needed to optimize vasoactive agent selection and sequencing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Critical Care, Ondokuz Mayıs University School of Medicine, Samsun, Turkey.
- Division of Pediatric Critical Care, Etlik City Hospital, Ankara, Turkey.
- Division of Pediatric Critical Care, Osmangazi University School of Medicine, Eskişehir, Turkey.
- Division of Pediatric Critical Care, Adnan Menderes University School of Medicine, Aydın, Turkey.
- Division of Pediatric Critical Care, Cerrahpaşa University School of Medicine, İstanbul, Turkey.
- Division of Pediatric Critical Care, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey.
ORCID-Profile: Muhammed Üdürgücü, Betül Demir Akyüz, Büşra Daştan İnce, Zeynelabidin Öztürk, Emrah Gün, Gürkan Bozan, Hatice Feray Arı, Güntülü Şık, Muhterem Duyu
Zitieren
APA
Üdürgücü, M., Yener, N., Akyüz, B. D., İnce, B. D., Öztürk, Z., Gün, E., Bozan, G., Arı, H. F., Şık, G., Duyu, M., & Septic Shock Study Group (2026). Management and Outcome of Paediatric Septic Shock Requiring Vasoactive Therapy: A Multicentre Prospective Observational Study. Acta Paediatrica. https://doi.org/10.1111/apa.70830
Vancouver
Üdürgücü M, Yener N, Akyüz BD, İnce BD, Öztürk Z, Gün E, et al. Management and Outcome of Paediatric Septic Shock Requiring Vasoactive Therapy: A Multicentre Prospective Observational Study. Acta Paediatrica. 2026. doi:10.1111/apa.70830
BibTeX
@article{drgc2026,
author = {Üdürgücü, Muhammed and Yener, Nazik and Akyüz, Betül Demir and İnce, Büşra Daştan and Öztürk, Zeynelabidin and Gün, Emrah and Bozan, Gürkan and Arı, Hatice Feray and Şık, Güntülü and Duyu, Muhterem and Septic Shock Study Group, Septic Shock Study Group},
title = {Management and Outcome of Paediatric Septic Shock Requiring Vasoactive Therapy: A Multicentre Prospective Observational Study},
journal = {Acta Paediatrica},
year = {2026},
doi = {10.1111/apa.70830}
}
EUVIMED